HomeORKA • NASDAQ
add
Oruka Therapeutics Inc
Previous close
$23.87
Day range
$22.51 - $24.44
Year range
$22.51 - $31.13
Market cap
799.02M USD
Avg Volume
32.51K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 21.49M | — |
Net income | -22.24M | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -21.49M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.12M | — |
Total assets | 20.18M | — |
Total liabilities | 46.23M | — |
Total equity | -26.05M | — |
Shares outstanding | 29.40M | — |
Price to book | -1.00 | — |
Return on assets | -188.92% | — |
Return on capital | -306.25% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -22.24M | — |
Cash from operations | -9.67M | — |
Cash from investing | — | — |
Cash from financing | 26.32M | — |
Net change in cash | 16.65M | — |
Free cash flow | 3.60M | — |
About
Headquarters
Website
Employees
5
